Anzeige
Meldung des Tages: Das Triple-Discovery-Setup, das der Markt noch nicht begriffen hat!!

10x Genomics News

Aktie
WKN:  A2PPQJ ISIN:  US88025U1097 US-Symbol:  TXG Branche:  Gesundheitswesen: Anbieter u. Dienstleister Land:  USA
20,46 $
-0,465 $
-2,22%
17,620 € 10.03.26
Depot/Watchlist
Marktkapitalisierung *
1,50 Mrd. €
Streubesitz
-
KGV
-9,57
Index-Zuordnung
-

10x Genomics News

19.02.26 - PR Newswire
10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference
10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference PR Newswire
12.02.26 - PR Newswire
10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026
10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026 PR Newswire
04.02.26 - PR Newswire
PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology
PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology PR Newswire
22.01.26 - PR Newswire
10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026
10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 PR Newswire
12.01.26 - PR Newswire
10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease
10x Genomics Launches Study to Advance Research in Blood-​Based Diagnostics for Autoimmune Disease PR Newswire
12.01.26 - PR Newswire
Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology
Cancer Research Institute Launches Transformative AI-Driven Immuno-​Oncology Initiative Powered by 10x Genomics Technology PR Newswire
11.01.26 - PR Newswire
10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results
10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results PR Newswire
29.12.25 - PR Newswire
10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference
10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference PR Newswire
18.11.25 - PR Newswire
New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium
New ASTRA Consortium Unites Asia-​Pacific Scientists to Build Pan-​Cancer Spatial Atlas Powered by 10x Genomics' Xenium PR Newswire
11.11.25 - PR Newswire
10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025
10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025 PR Newswire
06.11.25 - PR Newswire
10x Genomics Reports Third Quarter 2025 Financial Results
10x Genomics Reports Third Quarter 2025 Financial Results PR Newswire
29.10.25 - PR Newswire
Soaring Prices and Relentless Buying Create Perfect Storm for Gold Miners
Soaring Prices and Relentless Buying Create Perfect Storm for Gold Miners PR Newswire
29.10.25 - PR Newswire
Soaring Prices and Relentless Buying Create Perfect Storm for Gold Miners
Soaring Prices and Relentless Buying Create Perfect Storm for Gold Miners PR Newswire
29.10.25 - PR Newswire
10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research
10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research PR Newswire
20.10.25 - PR Newswire
10x Genomics and Anthropic Partner to Make Single Cell and Spatial Analysis More Accessible Through Claude for Life Sciences
10x Genomics and Anthropic Partner to Make Single Cell and Spatial Analysis More Accessible Through Claude for Life Sciences PR Newswire
19.10.25 - Maximilian Berger
Sonntag: 10X GENOMICS INC – Jetzt darf nichts verpasst werden!
Die Aktie von 10X Genomics (WKN A2PPQJ) zeigt sich stabil. Am Sonntag lohnt ein Blick auf Trends und Chancen rund um die Genomik-​Innovation.
09.10.25 - PR Newswire
10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025
10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025 PR Newswire
09.09.25 - PR Newswire
CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics
CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics PR Newswire
19.08.25 - PR Newswire
10x Genomics Launches Xenium Protein, Advancing Spatial Biology by Enabling Same-Cell RNA and Protein Analysis
10x Genomics Launches Xenium Protein, Advancing Spatial Biology by Enabling Same-Cell RNA and Protein Analysis PR Newswire
07.08.25 - PR Newswire
10x Genomics Reports Second Quarter 2025 Financial Results
10x Genomics Reports Second Quarter 2025 Financial Results PR Newswire

Newssuche

Videos

newspaper
10.03.26 +38,58%
Technical Trading: DAX Long Chance
DAX Long Typ: Turbo Open End WKN: VK2CGA Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »